Delayed Hypersensitivity to Intralesional Meglumine Antimoniate for Cutaneous Leishmaniasis
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.25-0210 ↗Kurz gefasst
Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Owain Donnelly und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Antiprotozoal Agents, Organometallic Compounds, Meglumine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Intralesional injection of pentavalent antimonials is a recommended treatment of cutaneous leishmaniasis (CL). We describe an allergic response to meglumine antimoniate after intralesional treatment of a CL lesion. A 61-year-old male resident of the United Kingdom developed an enlarging, nontender nodule on the right earlobe. Histological analysis and polymerase chain reaction testing confirmed a diagnosis of CL. Intralesional therapy with meglumine antimoniate was initiated, and two infiltrations were completed. After each administration, localized swelling and erythema were noted, and after the second infiltration, an urticarial rash also appeared on the patient’s hands. An immunological hypersensitivity reaction, with mixed Type I and Type IV features, was suspected, and treatment was discontinued. The patient declined further treatment, and the lesion gradually resolved, with full recovery 36 months after the first treatment. Recent travel history suggested Spain as the most likely country of acquisition. This report also reviews the literature on allergy to antimonial drugs. The prevalence of pentavalent antimonial hypersensitivity varies considerably between studies, likely due to differences in reporting of adverse events. Clinicians treating leishmaniasis should be aware of this adverse effect of antimonials, which may require use of alternative therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
- Clinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Department of Dermatology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Zitieren
APA
Donnelly, O., Checkley, A. M., & Walker, S. L. (2025). Delayed Hypersensitivity to Intralesional Meglumine Antimoniate for Cutaneous Leishmaniasis. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0210
Vancouver
Donnelly O, Checkley AM, Walker SL. Delayed Hypersensitivity to Intralesional Meglumine Antimoniate for Cutaneous Leishmaniasis. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.25-0210
BibTeX
@article{Donnelly2025,
author = {Donnelly, Owain and Checkley, Anna M and Walker, Stephen L},
title = {Delayed Hypersensitivity to Intralesional Meglumine Antimoniate for Cutaneous Leishmaniasis},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.25-0210}
}
EUVIMED